Arteris Raises 2026 Guidance After Strong Q1, Completes Cycuity Acquisition
Arteris does not produce chips. Instead, it supplies network‑on‑chip (NoC) interconnect intellectual property (IP) that lets semiconductor designers route data inside system‑on‑chip (SoC) devices. Its flagship FlexNoC® has shipped in more than four billion units as of February 12, 2026. Other IP offerings include the non‑coherent FlexGen®, cache‑coherent Ncore™, and last‑level‑cache CodaCache®. In addition to IP, Arteris provides SoC integration automation software, and following the Cycuity deal it now offers hardware‑security tools such as Cycuity® Radix‑S, Radix‑M, and Radix‑ST.
Financially, Q1 2026 revenue hit $22.9 million, a 39% increase from the same quarter a year earlier. Annual contract value (ACV) and royalties reached a record $92.8 million, also up 39% YoY. Management lifted its FY 2026 revenue guidance to a range of $91 million to $95 million, citing sustained demand for NoC IP in AI, data‑center, automotive, and enterprise SoC designs.
Operating results were mixed. GAAP operating loss widened to $9.3 million, largely due to a one‑off cost tied to the Cycuity acquisition and increased amortization and stock‑based expenses. Non‑GAAP operating loss narrowed to $2.5 million, a modest improvement over the prior year. Cash and cash equivalents at quarter‑end were $41.9 million, with no debt on the balance sheet. Operating cash flow was negative $7.1 million, and investing cash flow was negative $16 million, the latter driven by the acquisition. Management projects free cash flow of $5 million to $9 million for FY 2026.
The Cycuity acquisition is intended to bolster Arteris’s presence in security‑sensitive verticals. Management noted that aerospace and defense now account for nearly 10% of ACV, a rise attributed to the new security capabilities. The company also highlighted that its enterprise data‑center business remains the largest revenue generator, slightly surpassing automotive.
Arteris’s performance mirrors broader AI infrastructure spending trends. Gartner projects AI spending to grow 47% YoY to $2.6 trillion in 2026, driven by continued adoption of generative AI models. Arteris’s NoC IP is integral to AI accelerator design, and its revenue guidance assumes a 32% YoY growth at the midpoint of the revised range.
The stock has rebounded sharply since the 2021 IPO. After falling below $10 in 2023, the share price climbed from $7.7 in June 2025 to nearly $37 in June 2026, an almost five‑fold increase. Analysts have maintained a buy rating, citing the company’s unique market position and the upward revision of its guidance.
Looking ahead, Arteris faces the challenge of turning top‑line growth into sustainable profitability. While the company projects positive free cash flow for FY 2026, it remains unprofitable on a GAAP basis and has limited debt. Management’s focus will be on integrating Cycuity’s security tools and sustaining momentum in AI‑driven SoC markets.
In summary, Arteris’s Q1 2026 results and the Cycuity acquisition signal a strengthening of its IP portfolio and a bullish outlook for its revenue guidance. Investors will continue to monitor the company’s ability to achieve GAAP profitability and to capitalize on the expanding AI chip market.